These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37114476)

  • 21. Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.
    Muendlein A; Geiger K; Heinzle C; Gaenger S; Winder T; Severgnini L; Reimann P; Brandtner EM; Leiherer A; Drexel H; Decker T; Nonnenbroich C; Dechow T
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6435-6444. PubMed ID: 36763171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
    Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
    Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three novel mutations of APC gene in Chinese patients with familial adenomatous polyposis.
    Liu Q; Li X; Li S; Qu S; Wang Y; Tang Q; Ma H; Luo Y
    Tumour Biol; 2016 Aug; 37(8):11421-7. PubMed ID: 27000756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer.
    Xu T; Zhang Y; Zhang J; Qi C; Liu D; Wang Z; Li Y; Ji C; Li J; Lin X; Hou T; Liu H; Zhang L; Han-Zhang H; Shen L; Wang X
    Front Oncol; 2020; 10():568911. PubMed ID: 33194656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of gene variation in All-
    Tao H; Shen M; Zhang X; Wang M; Wu Y; Sun H; Ling C; Yang Y; Chen K; Li D
    J Gastrointest Oncol; 2022 Dec; 13(6):3009-3024. PubMed ID: 36636055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
    Fernández Montes A; Alonso Orduña V; Asensio Martínez E; Rodríguez Salas N; Torres E; Cacho Lavín D; Rodríguez Alonso RM; Falcó E; Oliva JC; Cirera L; García Gómez J; Pericay C
    Oncologist; 2023 Oct; 28(10):e902-e909. PubMed ID: 37141400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
    Zhan J; Li X; Yu Z; Yuan YH; Hou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
    Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC haploinsufficiency, but not CTNNB1 or CDH1 gene mutations, accounts for a fraction of familial adenomatous polyposis patients without APC truncating mutations.
    Venesio T; Balsamo A; Rondo-Spaudo M; Varesco L; Risio M; Ranzani GN
    Lab Invest; 2003 Dec; 83(12):1859-66. PubMed ID: 14691304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
    Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
    Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
    Wang D; Liang S; Zhang Z; Zhao G; Hu Y; Liang S; Zhang X; Banerjee S
    Oncotarget; 2017 Mar; 8(13):21327-21335. PubMed ID: 28423518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.
    Spier I; Drichel D; Kerick M; Kirfel J; Horpaopan S; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Perner S; Hoffmann P; Kristiansen G; Timmermann B; Nöthen MM; Holinski-Feder E; Schweiger MR; Aretz S
    J Med Genet; 2016 Mar; 53(3):172-9. PubMed ID: 26613750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas.
    Grover S; Kastrinos F; Steyerberg EW; Cook EF; Dewanwala A; Burbidge LA; Wenstrup RJ; Syngal S
    JAMA; 2012 Aug; 308(5):485-492. PubMed ID: 22851115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations.
    Cercek A; Braghiroli MI; Chou JF; Hechtman JF; Kemeny N; Saltz L; Capanu M; Yaeger R
    Clin Cancer Res; 2017 Aug; 23(16):4753-4760. PubMed ID: 28446505
    [No Abstract]   [Full Text] [Related]  

  • 36. Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis.
    Kim B; Won D; Jang M; Kim H; Choi JR; Kim TI; Lee ST
    BMC Med Genomics; 2019 Jul; 12(1):103. PubMed ID: 31269945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.
    Chiang JM; Wu Chou YH; Ma SC; Chen JR
    Virchows Arch; 2004 Nov; 445(5):465-71. PubMed ID: 15449054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
    Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
    Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
    Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
    Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
    Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
    BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.